Mechanical Characterization of Vestibular Schwannoma: Classification Based on Magnetic Resonance Elastography and Its Clinical Relevance Study

November 12, 2026 updated by: Anhua Wu, Shengjing Hospital

Biomechanical Prediction of Preoperative Magnetic Resonance Elastography for Vestibular Schwannoma: Tumor Stiffness, Adhesion and Surgical Outcomes

This retrospective study aims at investigating the value of preoperative magnetic resonance elastography (MRE) in assessing the biomechanical characteristics of vestibular schwannomas and predicting surgical risk. Tumor stiffness and three-dimensional adhesion characteristics will be quantitatively analyzed and correlated with clinical parameters, including intraoperative tumor consistency and adhesion severity, operative time, blood loss, and postoperative neurological function. The study aims to validate the associations between MRE-derived imaging parameters, intraoperative findings, and clinical outcomes, thereby providing an imaging-based foundation for preoperative risk assessment and individualized surgical planning for vestibular schwannomas.

Study Overview

Status

Recruiting

Detailed Description

Vestibular schwannomas exhibit considerable variability in tumor stiffness and adhesion to surrounding tissues, which may influence surgical complexity, the extent of resection, and postoperative neurological recovery. Conventional magnetic resonance imaging (MRI) provides information on tumor morphology and its anatomical relationships with adjacent structures; however, it remains limited in quantitatively characterizing intratumoral stiffness and three-dimensionally assessing adhesion characteristics at the tumor interface. This study aims to systematically evaluate the ability of magnetic resonance elastography to quantitatively characterize the biomechanical properties of vestibular schwannomas and explore its clinical utility in preoperative surgical risk stratification.

All participants will undergo conventional preoperative MRI and MRE examinations. Relevant clinical data, including hearing status and facial nerve function, will also be collected. Post-processing of MRE images will be performed to extract quantitative parameters reflecting tumor stiffness and generate stiffness distribution maps across different tumor regions. In addition, three-dimensional sliding interface imaging-related techniques will be used to characterize adhesion features at the interface between the tumor and adjacent tissues, enabling a comprehensive assessment of spatial heterogeneity in tumor stiffness and the biomechanical properties of tissue interfaces.During surgery, intraoperative findings, including tumor consistency, adhesion severity, operative time, intraoperative blood loss, and extent of tumor resection, will be systematically documented. Postoperative facial nerve function, hearing outcomes, and relevant histopathological data will also be collected.

Statistical analyses will be selected according to the nature of the outcome variables and will include correlation analyses, regression analyses, and receiver operating characteristic (ROC) curve analyses to evaluate the diagnostic performance of MRE parameters and their associations with surgical outcomes. The potential predictive value of tumor stiffness and adhesion characteristics for clinical outcomes, particularly postoperative facial nerve function, will be further explored. This study aims to establish an integrated framework linking preoperative quantitative imaging measurements with intraoperative biomechanical findings and postoperative clinical outcomes, thereby providing an imaging-based foundation for preoperative risk assessment, and individualized clinical decision-making in patients with vestibular schwannomas.

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Liaoning
      • Shenyang, Liaoning, China, 110000
        • Recruiting
        • Shengjing hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

This study will enroll adult patients with unilateral sporadic vestibular schwannoma who are scheduled to undergo microsurgical resection at Shengjing hospital.

Description

Inclusion Criteria:

-All patients undergoing vestibular schwannoma resection surgery are eligible for inclusion in the study cohort.

Exclusion Criteria:

  • Patients with metallic implants or foreign bodies in their bodies (pacemakers, artificial metallic heart valves, metal joints, metal implants, and those who can not remove dentures, insulin pumps, or contraceptive rings)
  • Pregnant women in the first trimester (within three months)
  • Patients with severe claustrophobia or anxiety
  • Patients with severe fever
  • Patients who can not tolerate MRE
  • Patients with vascular malformations and aneurysms.
  • Patients who do not sign an informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: RETROSPECTIVE

Cohorts and Interventions

Group / Cohort
MRE group

Participants will undergo preoperative magnetic resonance elastography . Quantitative tumor stiffness parameters will be derived through image post-processing, and a three-dimensional map of tumor adhesion characteristics will be generated. MRE-derived imaging parameters will be analyzed in relation to intraoperative findings, including tumor consistency, adhesion severity, operative time, blood loss, and extent of resection. Postoperative facial nerve function, hearing outcomes, and relevant histopathological data will also be collected to evaluate the potential predictive value of MRE parameters for surgical risk and clinical outcomes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Association of Preoperative MRE-Derived Quantitative Parameters With Intraoperative Tumor Consistency and Adhesion Severity
Time Frame: From preoperative MRE examination to surgery; intraoperative assessments will be performed during tumor resection.

Quantitative tumor stiffness parameters and three-dimensional adhesion characteristics derived from preoperative magnetic resonance elastography will be analyzed and compared with intraoperative assessments of tumor consistency and adhesion severity. The ability of MRE-derived parameters to characterize the biomechanical properties of vestibular schwannomas will be evaluated. Correlation analyses and, where appropriate, receiver operating characteristic (ROC) curve analyses will be performed to assess the associations and discriminative performance of imaging parameters in relation to intraoperative findings.

From preoperative MRE examination to surgery; intraoperative assessments will be performed during tumor resection.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 10, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2027

Study Registration Dates

First Submitted

November 11, 2026

First Submitted That Met QC Criteria

November 12, 2026

First Posted (Actual)

November 18, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 12, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe